As per letter attached Approval of Scheme of Amalgamation and Merger of Sun Pharma Global FZE, an indirect wholly owned subsidiary of the Company, into the Company by the Board of Directors at its meeting held on July 31, 2020 For further details refer the attached letter As per letter attached (As Per BSE Announcement dated on 16.03.2021) Sanction of Scheme of Amalgamation and Merger of Sun Pharma Global FZE with Sun Pharmaceutical Industries Limited ('Company'), by the Hon''ble National Company Law Tribunal As per letter attached (As Per BSE Announcement Dated on 16.09.2021)